Pancreatic And Bile Duct Stone Management Comprehensive Study by Type (ERCP Catheters, Guidewires, Sphincterotomes, Dilation Balloon Catheters, Extraction Balloon Catheters, Extraction Basket Catheters, Biliary Stents, Self-expandable Biliary Stents, Dilation Large-balloon Catheters, Mechanical Lithotripsy, Electrohydraulic/Laser Lithotripsy), Indication (Pancreatic Stones, Bile Duct Stone), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) Players and Region - Global Market Outlook to 2026

Pancreatic And Bile Duct Stone Management Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Pancreatic And Bile Duct Stone Management Market Scope?
Advances in endoscopic imaging techniques and high-tech, minimally invasive stone quarrying products are key drivers in the growth of the pancreatic and biliary tree management market. Clinical efficacy and safety gaps are closed by leading players in the industry through extensive technical advances by channeling high research and development funds. Increasing research funding and exclusive technological developments are becoming a major force in establishing clinical efficacy and safety with minimal post-operative complications, leading to greater adoption of stone management devices like self-expanding stents, ERCP extraction catheters, and sphincterotome products. Leading manufacturers in the Pancreatic and Bile Duct Stone Management market are focusing on various deals and outside collaborative approaches to increase their sales and market presence.

The Pancreatic And Bile Duct Stone Management market study is being classified by Type (ERCP Catheters, Guidewires, Sphincterotomes, Dilation Balloon Catheters, Extraction Balloon Catheters, Extraction Basket Catheters, Biliary Stents, Self-expandable Biliary Stents, Dilation Large-balloon Catheters, Mechanical Lithotripsy and Electrohydraulic/Laser Lithotripsy) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Pancreatic And Bile Duct Stone Management market throughout the predicted period.

Boston Scientific Corporation (United States), Olympus America Inc. (United States), Cook Medical (United States), Conmed (United States), CR BARD Inc. (Becton, Dickinson, and Company) (United States), Cordis (Cardinal Health Inc.) (United States), Zeon Medical Co., Ltd. (Japan), Medi-Globe (ENDO-Flex) GmbH (Germany) and Taewoong Medical Co., Ltd. (South Korea) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Pancreatic And Bile Duct Stone Management market by Type, Application and Region.

On the basis of geography, the market of Pancreatic And Bile Duct Stone Management has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
In May 2019, Cook Medical and Ambu A / S announced a collaboration to treat endoscope-related infections. This is a partnership under which Cook will distribute Ambus single-use single-use duodenoscopes in the United States following FDA approval.
In November 2018, Cook Medical Inc. began selling Taewoong Medical products in the United States. In this distribution, the business includes specialty products such as the Niti-S TTS esophageal stent and the Niti-S biliary stent. and In 2019, Boston Scientific Corporation received U.S. FDA Pre-Market Notification 510 (k) for its Class II ERCP Sphincterotome - Class II Stonetome Stone Removal Device.


Influencing Market Trend
  • Rising Global Adoption of Minimally-Invasive Stone Extraction Procedures
  • A Rise in Extensive Clinical Research
  • Increasing Launches of Highly Sophisticated Endoscopic Medical Devices

Market Drivers
  • Rising Prevalence of Common Bile Duct and Pancreatic Stone Diseases
  • Increasing Stone Retrieval Procedures
  • Early Diagnosis, And Increasing Awareness among the Population

Opportunities
  • Rising Healthcare Expenditure and Increasing Public Awareness
  • Rapid Technological Advancements In Pancreatic and Bile Duct Stone Management Products

Restraints
  • Costs Associated With the Products

Challenges
  • Lack of Awareness about the Medical Conditions


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Pancreatic And Bile Duct Stone Management, Venture Capitalists and Private Equity Firms and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • ERCP Catheters
  • Guidewires
  • Sphincterotomes
  • Dilation Balloon Catheters
  • Extraction Balloon Catheters
  • Extraction Basket Catheters
  • Biliary Stents
  • Self-expandable Biliary Stents
  • Dilation Large-balloon Catheters
  • Mechanical Lithotripsy
  • Electrohydraulic/Laser Lithotripsy
By Indication
  • Pancreatic Stones
  • Bile Duct Stone

By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Common Bile Duct and Pancreatic Stone Diseases
      • 3.2.2. Increasing Stone Retrieval Procedures
      • 3.2.3. Early Diagnosis, And Increasing Awareness among the Population
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness about the Medical Conditions
    • 3.4. Market Trends
      • 3.4.1. Rising Global Adoption of Minimally-Invasive Stone Extraction Procedures
      • 3.4.2. A Rise in Extensive Clinical Research
      • 3.4.3. Increasing Launches of Highly Sophisticated Endoscopic Medical Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pancreatic And Bile Duct Stone Management, by Type, Indication, End User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pancreatic And Bile Duct Stone Management (Value)
      • 5.2.1. Global Pancreatic And Bile Duct Stone Management by: Type (Value)
        • 5.2.1.1. ERCP Catheters
        • 5.2.1.2. Guidewires
        • 5.2.1.3. Sphincterotomes
        • 5.2.1.4. Dilation Balloon Catheters
        • 5.2.1.5. Extraction Balloon Catheters
        • 5.2.1.6. Extraction Basket Catheters
        • 5.2.1.7. Biliary Stents
        • 5.2.1.8. Self-expandable Biliary Stents
        • 5.2.1.9. Dilation Large-balloon Catheters
        • 5.2.1.10. Mechanical Lithotripsy
        • 5.2.1.11. Electrohydraulic/Laser Lithotripsy
      • 5.2.2. Global Pancreatic And Bile Duct Stone Management by: Indication (Value)
        • 5.2.2.1. Pancreatic Stones
        • 5.2.2.2. Bile Duct Stone
      • 5.2.3. Global Pancreatic And Bile Duct Stone Management by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory Surgical Centers
        • 5.2.3.3. Specialty Clinics
      • 5.2.4. Global Pancreatic And Bile Duct Stone Management Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Pancreatic And Bile Duct Stone Management (Price)
      • 5.3.1. Global Pancreatic And Bile Duct Stone Management by: Type (Price)
  • 6. Pancreatic And Bile Duct Stone Management: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boston Scientific Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Olympus America Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cook Medical (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Conmed (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. CR BARD Inc. (Becton, Dickinson, and Company) (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cordis (Cardinal Health Inc.) (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Zeon Medical Co., Ltd. (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medi-Globe (ENDO-Flex) GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Taewoong Medical Co., Ltd. (South Korea)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Pancreatic And Bile Duct Stone Management Sale, by Type, Indication, End User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pancreatic And Bile Duct Stone Management (Value)
      • 7.2.1. Global Pancreatic And Bile Duct Stone Management by: Type (Value)
        • 7.2.1.1. ERCP Catheters
        • 7.2.1.2. Guidewires
        • 7.2.1.3. Sphincterotomes
        • 7.2.1.4. Dilation Balloon Catheters
        • 7.2.1.5. Extraction Balloon Catheters
        • 7.2.1.6. Extraction Basket Catheters
        • 7.2.1.7. Biliary Stents
        • 7.2.1.8. Self-expandable Biliary Stents
        • 7.2.1.9. Dilation Large-balloon Catheters
        • 7.2.1.10. Mechanical Lithotripsy
        • 7.2.1.11. Electrohydraulic/Laser Lithotripsy
      • 7.2.2. Global Pancreatic And Bile Duct Stone Management by: Indication (Value)
        • 7.2.2.1. Pancreatic Stones
        • 7.2.2.2. Bile Duct Stone
      • 7.2.3. Global Pancreatic And Bile Duct Stone Management by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory Surgical Centers
        • 7.2.3.3. Specialty Clinics
      • 7.2.4. Global Pancreatic And Bile Duct Stone Management Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Pancreatic And Bile Duct Stone Management (Price)
      • 7.3.1. Global Pancreatic And Bile Duct Stone Management by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pancreatic And Bile Duct Stone Management: by Type(USD Million)
  • Table 2. Pancreatic And Bile Duct Stone Management ERCP Catheters , by Region USD Million (2015-2020)
  • Table 3. Pancreatic And Bile Duct Stone Management Guidewires , by Region USD Million (2015-2020)
  • Table 4. Pancreatic And Bile Duct Stone Management Sphincterotomes , by Region USD Million (2015-2020)
  • Table 5. Pancreatic And Bile Duct Stone Management Dilation Balloon Catheters , by Region USD Million (2015-2020)
  • Table 6. Pancreatic And Bile Duct Stone Management Extraction Balloon Catheters , by Region USD Million (2015-2020)
  • Table 7. Pancreatic And Bile Duct Stone Management Extraction Basket Catheters , by Region USD Million (2015-2020)
  • Table 8. Pancreatic And Bile Duct Stone Management Biliary Stents , by Region USD Million (2015-2020)
  • Table 9. Pancreatic And Bile Duct Stone Management Self-expandable Biliary Stents , by Region USD Million (2015-2020)
  • Table 10. Pancreatic And Bile Duct Stone Management Dilation Large-balloon Catheters , by Region USD Million (2015-2020)
  • Table 11. Pancreatic And Bile Duct Stone Management Mechanical Lithotripsy , by Region USD Million (2015-2020)
  • Table 12. Pancreatic And Bile Duct Stone Management Electrohydraulic/Laser Lithotripsy , by Region USD Million (2015-2020)
  • Table 13. Pancreatic And Bile Duct Stone Management: by Indication(USD Million)
  • Table 14. Pancreatic And Bile Duct Stone Management Pancreatic Stones , by Region USD Million (2015-2020)
  • Table 15. Pancreatic And Bile Duct Stone Management Bile Duct Stone , by Region USD Million (2015-2020)
  • Table 16. Pancreatic And Bile Duct Stone Management: by End User(USD Million)
  • Table 17. Pancreatic And Bile Duct Stone Management Hospitals , by Region USD Million (2015-2020)
  • Table 18. Pancreatic And Bile Duct Stone Management Ambulatory Surgical Centers , by Region USD Million (2015-2020)
  • Table 19. Pancreatic And Bile Duct Stone Management Specialty Clinics , by Region USD Million (2015-2020)
  • Table 20. South America Pancreatic And Bile Duct Stone Management, by Country USD Million (2015-2020)
  • Table 21. South America Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 22. South America Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 23. South America Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 24. Brazil Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 25. Brazil Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 26. Brazil Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 27. Argentina Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 28. Argentina Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 29. Argentina Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 30. Rest of South America Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 32. Rest of South America Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 33. Asia Pacific Pancreatic And Bile Duct Stone Management, by Country USD Million (2015-2020)
  • Table 34. Asia Pacific Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 35. Asia Pacific Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 36. Asia Pacific Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 37. China Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 38. China Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 39. China Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 40. Japan Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 41. Japan Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 42. Japan Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 43. India Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 44. India Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 45. India Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 46. South Korea Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 47. South Korea Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 48. South Korea Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 49. Taiwan Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 50. Taiwan Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 51. Taiwan Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 52. Australia Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 53. Australia Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 54. Australia Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 56. Rest of Asia-Pacific Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 57. Rest of Asia-Pacific Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 58. Europe Pancreatic And Bile Duct Stone Management, by Country USD Million (2015-2020)
  • Table 59. Europe Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 60. Europe Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 61. Europe Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 62. Germany Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 63. Germany Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 64. Germany Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 65. France Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 66. France Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 67. France Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 68. Italy Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 69. Italy Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 70. Italy Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 71. United Kingdom Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 72. United Kingdom Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 73. United Kingdom Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 74. Netherlands Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 75. Netherlands Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 76. Netherlands Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 77. Rest of Europe Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 78. Rest of Europe Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 79. Rest of Europe Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 80. MEA Pancreatic And Bile Duct Stone Management, by Country USD Million (2015-2020)
  • Table 81. MEA Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 82. MEA Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 83. MEA Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 84. Middle East Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 85. Middle East Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 86. Middle East Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 87. Africa Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 88. Africa Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 89. Africa Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 90. North America Pancreatic And Bile Duct Stone Management, by Country USD Million (2015-2020)
  • Table 91. North America Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 92. North America Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 93. North America Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 94. United States Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 95. United States Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 96. United States Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 97. Canada Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 98. Canada Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 99. Canada Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 100. Mexico Pancreatic And Bile Duct Stone Management, by Type USD Million (2015-2020)
  • Table 101. Mexico Pancreatic And Bile Duct Stone Management, by Indication USD Million (2015-2020)
  • Table 102. Mexico Pancreatic And Bile Duct Stone Management, by End User USD Million (2015-2020)
  • Table 103. Pancreatic And Bile Duct Stone Management: by Type(USD/Units)
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Pancreatic And Bile Duct Stone Management: by Type(USD Million)
  • Table 114. Pancreatic And Bile Duct Stone Management ERCP Catheters , by Region USD Million (2021-2026)
  • Table 115. Pancreatic And Bile Duct Stone Management Guidewires , by Region USD Million (2021-2026)
  • Table 116. Pancreatic And Bile Duct Stone Management Sphincterotomes , by Region USD Million (2021-2026)
  • Table 117. Pancreatic And Bile Duct Stone Management Dilation Balloon Catheters , by Region USD Million (2021-2026)
  • Table 118. Pancreatic And Bile Duct Stone Management Extraction Balloon Catheters , by Region USD Million (2021-2026)
  • Table 119. Pancreatic And Bile Duct Stone Management Extraction Basket Catheters , by Region USD Million (2021-2026)
  • Table 120. Pancreatic And Bile Duct Stone Management Biliary Stents , by Region USD Million (2021-2026)
  • Table 121. Pancreatic And Bile Duct Stone Management Self-expandable Biliary Stents , by Region USD Million (2021-2026)
  • Table 122. Pancreatic And Bile Duct Stone Management Dilation Large-balloon Catheters , by Region USD Million (2021-2026)
  • Table 123. Pancreatic And Bile Duct Stone Management Mechanical Lithotripsy , by Region USD Million (2021-2026)
  • Table 124. Pancreatic And Bile Duct Stone Management Electrohydraulic/Laser Lithotripsy , by Region USD Million (2021-2026)
  • Table 125. Pancreatic And Bile Duct Stone Management: by Indication(USD Million)
  • Table 126. Pancreatic And Bile Duct Stone Management Pancreatic Stones , by Region USD Million (2021-2026)
  • Table 127. Pancreatic And Bile Duct Stone Management Bile Duct Stone , by Region USD Million (2021-2026)
  • Table 128. Pancreatic And Bile Duct Stone Management: by End User(USD Million)
  • Table 129. Pancreatic And Bile Duct Stone Management Hospitals , by Region USD Million (2021-2026)
  • Table 130. Pancreatic And Bile Duct Stone Management Ambulatory Surgical Centers , by Region USD Million (2021-2026)
  • Table 131. Pancreatic And Bile Duct Stone Management Specialty Clinics , by Region USD Million (2021-2026)
  • Table 132. South America Pancreatic And Bile Duct Stone Management, by Country USD Million (2021-2026)
  • Table 133. South America Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 134. South America Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 135. South America Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 136. Brazil Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 137. Brazil Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 138. Brazil Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 139. Argentina Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 140. Argentina Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 141. Argentina Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 142. Rest of South America Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 143. Rest of South America Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 144. Rest of South America Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 145. Asia Pacific Pancreatic And Bile Duct Stone Management, by Country USD Million (2021-2026)
  • Table 146. Asia Pacific Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 147. Asia Pacific Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 148. Asia Pacific Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 149. China Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 150. China Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 151. China Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 152. Japan Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 153. Japan Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 154. Japan Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 155. India Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 156. India Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 157. India Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 158. South Korea Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 159. South Korea Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 160. South Korea Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 161. Taiwan Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 162. Taiwan Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 163. Taiwan Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 164. Australia Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 165. Australia Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 166. Australia Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 167. Rest of Asia-Pacific Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 168. Rest of Asia-Pacific Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 169. Rest of Asia-Pacific Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 170. Europe Pancreatic And Bile Duct Stone Management, by Country USD Million (2021-2026)
  • Table 171. Europe Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 172. Europe Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 173. Europe Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 174. Germany Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 175. Germany Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 176. Germany Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 177. France Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 178. France Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 179. France Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 180. Italy Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 181. Italy Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 182. Italy Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 183. United Kingdom Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 184. United Kingdom Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 185. United Kingdom Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 186. Netherlands Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 187. Netherlands Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 188. Netherlands Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 189. Rest of Europe Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 190. Rest of Europe Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 191. Rest of Europe Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 192. MEA Pancreatic And Bile Duct Stone Management, by Country USD Million (2021-2026)
  • Table 193. MEA Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 194. MEA Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 195. MEA Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 196. Middle East Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 197. Middle East Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 198. Middle East Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 199. Africa Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 200. Africa Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 201. Africa Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 202. North America Pancreatic And Bile Duct Stone Management, by Country USD Million (2021-2026)
  • Table 203. North America Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 204. North America Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 205. North America Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 206. United States Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 207. United States Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 208. United States Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 209. Canada Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 210. Canada Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 211. Canada Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 212. Mexico Pancreatic And Bile Duct Stone Management, by Type USD Million (2021-2026)
  • Table 213. Mexico Pancreatic And Bile Duct Stone Management, by Indication USD Million (2021-2026)
  • Table 214. Mexico Pancreatic And Bile Duct Stone Management, by End User USD Million (2021-2026)
  • Table 215. Pancreatic And Bile Duct Stone Management: by Type(USD/Units)
  • Table 216. Research Programs/Design for This Report
  • Table 217. Key Data Information from Secondary Sources
  • Table 218. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pancreatic And Bile Duct Stone Management: by Type USD Million (2015-2020)
  • Figure 5. Global Pancreatic And Bile Duct Stone Management: by Indication USD Million (2015-2020)
  • Figure 6. Global Pancreatic And Bile Duct Stone Management: by End User USD Million (2015-2020)
  • Figure 7. South America Pancreatic And Bile Duct Stone Management Share (%), by Country
  • Figure 8. Asia Pacific Pancreatic And Bile Duct Stone Management Share (%), by Country
  • Figure 9. Europe Pancreatic And Bile Duct Stone Management Share (%), by Country
  • Figure 10. MEA Pancreatic And Bile Duct Stone Management Share (%), by Country
  • Figure 11. North America Pancreatic And Bile Duct Stone Management Share (%), by Country
  • Figure 12. Global Pancreatic And Bile Duct Stone Management: by Type USD/Units (2015-2020)
  • Figure 13. Global Pancreatic And Bile Duct Stone Management share by Players 2020 (%)
  • Figure 14. Global Pancreatic And Bile Duct Stone Management share by Players (Top 3) 2020(%)
  • Figure 15. Global Pancreatic And Bile Duct Stone Management share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Boston Scientific Corporation (United States) Revenue: by Geography 2020
  • Figure 19. Olympus America Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Olympus America Inc. (United States) Revenue: by Geography 2020
  • Figure 21. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 22. Cook Medical (United States) Revenue: by Geography 2020
  • Figure 23. Conmed (United States) Revenue, Net Income and Gross profit
  • Figure 24. Conmed (United States) Revenue: by Geography 2020
  • Figure 25. CR BARD Inc. (Becton, Dickinson, and Company) (United States) Revenue, Net Income and Gross profit
  • Figure 26. CR BARD Inc. (Becton, Dickinson, and Company) (United States) Revenue: by Geography 2020
  • Figure 27. Cordis (Cardinal Health Inc.) (United States) Revenue, Net Income and Gross profit
  • Figure 28. Cordis (Cardinal Health Inc.) (United States) Revenue: by Geography 2020
  • Figure 29. Zeon Medical Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Zeon Medical Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 31. Medi-Globe (ENDO-Flex) GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Medi-Globe (ENDO-Flex) GmbH (Germany) Revenue: by Geography 2020
  • Figure 33. Taewoong Medical Co., Ltd. (South Korea) Revenue, Net Income and Gross profit
  • Figure 34. Taewoong Medical Co., Ltd. (South Korea) Revenue: by Geography 2020
  • Figure 35. Global Pancreatic And Bile Duct Stone Management: by Type USD Million (2021-2026)
  • Figure 36. Global Pancreatic And Bile Duct Stone Management: by Indication USD Million (2021-2026)
  • Figure 37. Global Pancreatic And Bile Duct Stone Management: by End User USD Million (2021-2026)
  • Figure 38. South America Pancreatic And Bile Duct Stone Management Share (%), by Country
  • Figure 39. Asia Pacific Pancreatic And Bile Duct Stone Management Share (%), by Country
  • Figure 40. Europe Pancreatic And Bile Duct Stone Management Share (%), by Country
  • Figure 41. MEA Pancreatic And Bile Duct Stone Management Share (%), by Country
  • Figure 42. North America Pancreatic And Bile Duct Stone Management Share (%), by Country
  • Figure 43. Global Pancreatic And Bile Duct Stone Management: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Boston Scientific Corporation (United States)
  • Olympus America Inc. (United States)
  • Cook Medical (United States)
  • Conmed (United States)
  • CR BARD Inc. (Becton, Dickinson, and Company) (United States)
  • Cordis (Cardinal Health Inc.) (United States)
  • Zeon Medical Co., Ltd. (Japan)
  • Medi-Globe (ENDO-Flex) GmbH (Germany)
  • Taewoong Medical Co., Ltd. (South Korea)
Select User Access Type

Key Highlights of Report


Apr 2021 245 Pages 61 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Pancreatic And Bile Duct Stone Management market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Pancreatic And Bile Duct Stone Management market are Boston Scientific Corporation (United States), Olympus America Inc. (United States), Cook Medical (United States), Conmed (United States), CR BARD Inc. (Becton, Dickinson, and Company) (United States), Cordis (Cardinal Health Inc.) (United States), Zeon Medical Co., Ltd. (Japan), Medi-Globe (ENDO-Flex) GmbH (Germany) and Taewoong Medical Co., Ltd. (South Korea), to name a few.
In this highly competitive & fast evolving Pancreatic And Bile Duct Stone Management industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Pancreatic And Bile Duct Stone Management Market Report?